Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction

Published:2021-02-10 Issue:2 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Pang Ran¹,Zhou Xin-Yao²,Wang Xiangling³,Wang Bin⁴,Yin Xue-Lai¹,Bo Hai¹,Jung Jae Hung⁵⁶

Affiliation:

1. Department of Urology; Guang An Men Hospital, China Academy of Chinese Medical Sciences; Beijing China

2. Internal Medicine & Outpatients Management Office; Guang An Men Hospital, China Academy of Chinese Medical Sciences; Beijing China

3. Division of Nephrology and Hypertension; Mayo Clinic; Rochester Minnesota USA

4. China Academy of Chinese Medical Sciences; Beijing China

5. Department of Urology; Yonsei University Wonju College of Medicine; Wonju Korea, South

6. Center of Evidence Based Medicine, Institute of Convergence Science; Yonsei University; Seoul Korea, South

Publisher

Wiley

Subject

Pharmacology (medical)

Reference124 articles.

1. Efficacy and safety of medium-to-long-term use of tolterodine extended release with or without tamsulosin in patients with benign prostate hyperplasia and larger prostate size: a double-blind, placebo-controlled, randomized clinical trial;Cai;Chinese Medical Journal,2016

2. A multicenter real-life study of the efficacy of an alpha-blocker with or without anticholinergic agent (imidafenacin) treatment in patients with lower urinary tract symptoms/benign prostatic hyperplasia and storage symptoms;Cho;European Urology, Supplements,2017

3. A multicenter real-life study of the efficacy of an alpha-blocker with or without anticholinergic agent (imidafenacin) treatment in patients with lower urinary tract symptoms/benign prostatic hyperplasia and storage symptoms;Cho;International Journal of Clinical Practice,2017

4. Combination of tamsulosin and solifenacin treatment for benign prostatic hyperplasia with overactive bladder;He;Practical Pharmacy and Clinical Remedies,2012

5. The efficacy and safety of combination therapy with alpha-blocker and low-dose propiverine hydrochloride for benign prostatic hyperplasia accompanied by overactive bladder symptoms;Kang;Korean Journal of Urology,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. G12/13 signaling in asthma;Respiratory Research;2024-08-02

2. Novel pharmacotherapeutic avenues for bladder storage dysfunction in men;Expert Opinion on Pharmacotherapy;2024-03-23

3. Medical Advancements in Benign Prostatic Hyperplasia Treatments;Current Urology Reports;2024-03-07

4. Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia;Expert Opinion on Drug Safety;2023-12-02

5. Konservative und medikamentöse Therapie des benignen Prostatasyndroms;Die Urologie;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3